Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Fabius, I think these are the numbers to keep track off and compare;

Quitapine Fum ER: monthly TRX Count

10/31
PAR:30.7K Acc: 29K Tru: 13K Astra: 10.8K Mall 3.3K Lup 1.9K
09/30
PAR:30.7K Acc: 27.3K Tru: 11.7K Astra: 11K Mall 2.6K Lup 0.4K
08/31
PAR:34.4K Acc: 27.6K Tru: 11.3K Astra: 12.5K Mall 1.7K Lup --
07/31
PAR:35.9K Acc: 24.1K Tru: 9.8K Astra: 11.5K Mall 0.6K Lup --

clearly we see the first ones who got approved locked n the largest contracts and market share. it also shows us the market ! 30k scripts for PAR 29k scripts for ACC and the lst goes on. compare those to MNK's 729 scripts. as we see the top dogs go down and ours go up we know and can gauge market penetration. again, based on the data we know our scripts are selling for around $677 per script. we can also calculate out what the others are selling theirs for. the only thing that will never be known is actual cost of a delivered product after adjustments which may even fluctuate. But we can gauge market penetration. which will at least tell us to expect better results moving forward, worse results or same as.

when just looking at total scripts from 2QE to 3QE we see seroquel ending with only 443 prescriptions. However, already as of last week we are now up to 726 prescriptions. NOT near Astra's 10k but its almost double. which tells me, expect about double the revenue we had the quarter before on Seroquel. so as long as Focalin stays consistent as it has been if we made 1.2 million in 3QE I expect us to make that to possibly 1.5 million for 4QE which is at least better than year over year last year.